Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

doi:10.1186/1750-9378-4-S2-O6

Infectious Agents and Cancer

Volume 4
Suppl 2

Viewing options:

Abstract
Full text
PDF (132KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Clifford GM
Rickenbach M
Franceschi S

on PubMed

Clifford GM
Rickenbach M
Franceschi S
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research .

Oral presentation

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

GM Clifford¹, M Rickenbach², S Franceschi¹ and the Swiss HIV Cohort Study

¹International Agency for Research on Cancer, Lyon, France

²Coordination and Data Center, Swiss HIV Cohort Study, Lausanne, Switzerland

corresponding author email

from 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Bethesda, MD, USA. 6–7 October 2008

Infectious Agents and Cancer 2009, 4(Suppl 2):O6doi:10.1186/1750-9378-4-S2-O6


Published:	17 June 2009

First paragraph (this article has no abstract)

To investigate HIV-related immunodeficiency as a risk factor for hepatocellular carcinoma (HCC) among persons infected with HIV, whilst controlling for the effect of frequent co-infection with hepatitis C and hepatitis B viruses.